Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Technologies, Thomas Scientific Ink Distribution Agreement for Genomics Products

NEW YORK ─ Thomas Scientific said on Tuesday that it has inked a strategic distribution agreement with Agilent Technologies that expands its molecular biology product portfolio.

Under the deal, Thomas Scientific will provide its customers with access to more than 700 bioreagent products from the genomics division of Santa Clara, California-based Agilent, including qPCR instruments, PCR enzymes, and other molecular biology reagents. To help satisfy growing demands from high complexity laboratories, Agilent's CRISPR libraries will also be available through Thomas Scientific.

Financial and other terms of the deal were not disclosed.

Swedesboro, New Jersey-based Thomas Scientific noted that from the time of its acquisition by the Carlyle Group in 2017, it has completed four strategic acquisitions that have helped it expand the reach of its distribution network. It also has other distribution agreements, including with MicroGEM, Reditus Laboratories, and Microbix Biosystems.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.